MedPath
FDA Product

Sumatriptan

Product approved by U.S. Food and Drug Administration (US)

Basic Information

Sumatriptan

63187-969

Regulatory Information

63187-969

ANDA078327

C73584

June 1, 2022

USA

These highlights do not include all the information needed to use SUMATRIPTAN TABLETS safely and effectively. See full prescribing information for SUMATRIPTAN TABLETS. SUMATRIPTAN tablets, for oral useInitial U.S. Approval: 1992

HUMAN PRESCRIPTION DRUG LABEL

5

Company Information

Proficient Rx LP

079196022

Active Ingredients

ANHYDROUS DIBASIC CALCIUM PHOSPHATE

Code: L11K75P92J

Class Code: IACT

POLYSORBATE 80

Code: 6OZP39ZG8H

Class Code: IACT

SUMATRIPTAN SUCCINATE

Quantity: 25 mg in 1 1

Code: J8BDZ68989

Class Code: ACTIM

CROSCARMELLOSE SODIUM

Code: M28OL1HH48

Class Code: IACT

MAGNESIUM STEARATE

Code: 70097M6I30

Class Code: IACT

MICROCRYSTALLINE CELLULOSE

Code: OP1R32D61U

Class Code: IACT

SODIUM BICARBONATE

Code: 8MDF5V39QO

Class Code: IACT

Active Moieties

SUMATRIPTAN

Code: 8R78F6L9VO

© Copyright 2025. All Rights Reserved by MedPath